Can Fite Biopharma Ltd CANF:NYSE American

RT Quote | NYSE American | USD
Last | 09/28/22 EDT
0.79quote price arrow up+0.037 (+4.91%)
Volume
27,669
52 week range
0.74 - 2.60
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.79
  • 52 Week High2.60
  • 52 Week High Date12/20/21
  • 52 Week Low0.74
  • 52 Week Low Date09/23/22

Key Stats

  • Market Cap20.24M
  • Shares Out27.19M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.35
  • YTD % Change-38.76

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.79
  • 52 Week High2.60
  • 52 Week High Date12/20/21
  • 52 Week Low0.74
  • 52 Week Low Date09/23/22
  • Market Cap20.24M
  • Shares Out27.19M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.35
  • YTD % Change-38.76

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date11/24/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Can Fite Biopharma Ltd

 

Profile

MORE
Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is...
Ilan Cohen
Chairman of the Board
Pnina Fishman Ph.D.
Chief Executive Officer, Director
Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Address
10 Bareket Street, Kiryat Matalon,
P.O. Box 7537
Petah Tikva
4951778
Israel

Top Peers

SYMBOLLASTCHG%CHG
SNGX
Soligenix Inc
0.48-0.0108-2.2005%
ACER
Acer Therapeutics Inc
1.54+0.09+6.21%
ONTX
Onconova Therapeutics Inc
0.9607+0.0606+6.73%
IKT
Inhibikase Therapeutics Inc
0.90+0.05+5.88%
ONCS
OncoSec Medical Inc
0.50UNCHUNCH